Photo from wikipedia
The benefits and risks of restarting antiplatelet therapy (APT) for patients with spontaneous intracranial haemorrhage (ICH) remain controversial. This meta‐analysis was performed to explore the efficacy and safety of restarting… Click to show full abstract
The benefits and risks of restarting antiplatelet therapy (APT) for patients with spontaneous intracranial haemorrhage (ICH) remain controversial. This meta‐analysis was performed to explore the efficacy and safety of restarting APT for these patients.
Keywords:
restarting antiplatelet;
antiplatelet therapy;
intracranial haemorrhage;
spontaneous intracranial;
patients spontaneous;
meta analysis
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!